Mouse Hoxd10 ELISA Kit (V2LY-0626-LY5873)

Li, Y., Ma, K., Xie, Q., Zhang, X., Zhang, X., Chen, K., ... & Qian, R. (2021). Identification of HOXD10 as a marker of poor prognosis in glioblastoma multiforme. OncoTargets and therapy, 5183-5195.

Lai, F. J., Yu, H., Xie, Y. Y., & He, N. (2021). Circ_0000317/microRNA‐520g/HOXD10 axis affects the biological characteristics of colorectal cancer. The Kaohsiung Journal of Medical Sciences, 37(11), 951-963.

Pan, W., Wang, K., Li, J., Li, H., Cai, Y., Zhang, M., ... & Weng, W. (2021). Restoring HOXD10 exhibits therapeutic potential for ameliorating malignant progression and 5-fluorouracil resistance in colorectal cancer. Frontiers in oncology, 11, 771528.

Ruan, Z., Li, Y., He, R., & Li, X. (2021). Inhibition of microRNA-10b-5p up-regulates HOXD10 to attenuate Alzheimer’s disease in rats via the Rho/ROCK signalling pathway. Journal of drug targeting, 29(5), 531-540.

Yang, F., Liu, D., Deng, Y., Wang, J., Mei, S., Ge, S., ... & Zhang, T. (2020). Frequent promoter methylation of HOXD10 in endometrial carcinoma and its pathological significance. Oncology Letters, 19(5), 3602-3608.

Lin, Z., Hu, Y., Lin, R., & Ye, H. (2020). The effect of overexpression of the HOXD10 gene on the malignant proliferation, invasion, and tumor formation of pancreatic cancer cell PANC-1. Gland Surgery, 9(2), 385.

Yuan, Y. H., Wang, H. Y., Lai, Y., Zhong, W., Liang, W. L., Yan, F. D., ... & Lin, Y. (2019). Epigenetic inactivation of HOXD10 is associated with human colon cancer via inhibiting the RHOC/AKT/MAPK signaling pathway. Cell Communication and Signaling, 17, 1-13.

Qi, Z., Yuan, L., & Sun, N. (2019). Propofol exhibits a tumor‑suppressive effect and regulates cell viability, migration and invasion in bladder carcinoma by targeting the microRNA‑10b/HOXD10 signaling pathway. Oncology Letters, 18(6), 6228-6236.

Cao, Y. M., Gu, J., Zhang, Y. S., Wei, W. J., Qu, N., Wen, D., ... & Zhu, Y. X. (2018). Aberrant hypermethylation of the HOXD10 gene in papillary thyroid cancer with BRAFV600E mutation. Oncology reports, 39(1), 338-348.

Yachi, K., Tsuda, M., Kohsaka, S., Wang, L., Oda, Y., Tanikawa, S., ... & Tanaka, S. (2018). miR-23a promotes invasion of glioblastoma via HOXD10-regulated glial-mesenchymal transition. Signal Transduction and Targeted Therapy, 3(1), 33.

Please try the standard protocols which include: protocols, troubleshooting and guide.

Enzyme-linked Immunosorbent Assay (ELISA)
Flow Cytometry
Immunofluorescence (IF)
Immunohistochemistry (IHC)
Immunoprecipitation (IP)
Western Blot (WB)
Enzyme Linked Immunospot (ELISpot)
Proteogenomic
Other Protocols